Angelo A Petropolis, MD - Medicare Dermatology in Sierra Vista, AZ

Angelo A Petropolis, MD is a medicare enrolled "Dermatology" physician in Sierra Vista, Arizona. He went to University Of Arizona College Of Medicine and graduated in 1985 and has 39 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Epiphany Dermatology Of Arizona Llc and his current practice location is 1916 Paseo San Luis, Sierra Vista, Arizona. You can reach out to his office (for appointments etc.) via phone at (520) 458-1505.

Angelo A Petropolis is licensed to practice in Arizona (license number 22192) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1457391732.

Contact Information

Angelo A Petropolis, MD
1916 Paseo San Luis,
Sierra Vista, AZ 85635
(520) 458-1505
(520) 458-6949



Physician's Profile

Full NameAngelo A Petropolis
GenderMale
SpecialityDermatology
Experience39 Years
Location1916 Paseo San Luis, Sierra Vista, Arizona
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Angelo A Petropolis attended and graduated from University Of Arizona College Of Medicine in 1985
  NPI Data:
  • NPI Number: 1457391732
  • Provider Enumeration Date: 06/07/2006
  • Last Update Date: 03/20/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4587562095
  • Enrollment ID: I20040618000774

Medical Identifiers

Medical identifiers for Angelo A Petropolis such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457391732NPI-NPPES
AZ0776240OtherBCBS AZ
325242MedicaidAZ
516118OtherAZAETNA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology 22192 (Arizona)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Epiphany Dermatology Of Arizona Llc983018136125

News Archive

Roxane Laboratories announces launch of Amlodipine Besylate tablets

Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.

Study: Combination treatment more than halves mortality rates for prostate cancer

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

Baffling chronic pain linked to rewiring of brain

Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising.

Researchers identify new immunotherapy treatment target for acute myeloid leukemia in children

Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Angelo A Petropolis allows following entities to bill medicare on his behalf.
Entity NameEpiphany Dermatology Of Arizona Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457465858
PECOS PAC ID: 9830181361
Enrollment ID: O20040402000307

News Archive

Roxane Laboratories announces launch of Amlodipine Besylate tablets

Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.

Study: Combination treatment more than halves mortality rates for prostate cancer

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

Baffling chronic pain linked to rewiring of brain

Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising.

Researchers identify new immunotherapy treatment target for acute myeloid leukemia in children

Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Angelo A Petropolis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Angelo A Petropolis, MD
7300 Ranch Road 2222, Building 1, Ste 200,
Austin, TX 78730

Ph: (512) 628-0465
Angelo A Petropolis, MD
1916 Paseo San Luis,
Sierra Vista, AZ 85635

Ph: (520) 458-1505

News Archive

Roxane Laboratories announces launch of Amlodipine Besylate tablets

Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.

Study: Combination treatment more than halves mortality rates for prostate cancer

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

Baffling chronic pain linked to rewiring of brain

Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising.

Researchers identify new immunotherapy treatment target for acute myeloid leukemia in children

Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.

Read more News

› Verified 5 days ago


Dermatology Doctors in Sierra Vista, AZ

Matthew Crosby, D.O.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1916 Paseo San Luis, Sierra Vista, AZ 85635
Phone: 520-458-1505    
Dr. Richard Helge Weyer, M.D.
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 165 El Camino Real, Sierra Vista, AZ 85635
Phone: 520-458-1787    Fax: 520-458-1519
Dr. Christopher William Weyer, D.O.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 150 S Coronado Dr Ste 110, Sierra Vista, AZ 85635
Phone: 520-458-1787    Fax: 520-458-1519

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.